Nikhil H. Ramaiya - Concepedia

Author

Nikhil H. Ramaiya

Also Known As

Aekta Gupta, N H Ramaiya, N Ramaiya, N. H. Ramaiya, N. Ramaiya, N.H. Ramaiya, Nikhil H Ramaiya, Nikhil H. Ramaiya, Nikhil Himmatsinh Ramaiya, Nikhil Ramaiya

423

Publications

18.1K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Brigham and Women's Hospital Harvard University Dana-Farber Brigham Cancer Center University Hospitals of Cleveland

About

Nikhil H. Ramaiya is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	53	4.8K
2	Health Sciences	13	16	854
3	Gastroenterology	11	11	275
4	Engineering	3	3	78
5	Cell Biology	1	1	851

Nikhil H. Ramaiya

135

Publications

10.9K

Citations

H-Index

Page 1

	Year	Citations
Crizotinib in<i>ALK</i>-Rearranged Inflammatory Myofibroblastic Tumor James E. Butrynski, David R. D’Adamo, Jason L. Hornick, New England Journal of Medicine Lymphoid NeoplasiaTumoral PathologyMalignant DiseaseAlk-translocated ImtPathology	2010	851
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients F. Stephen Hodi, Marcus O. Butler, Darryl A. Oble, Proceedings of the National Academy of Sciences Antibody BlockadeTumor DestructionImmunologyImmune RegulationImmunoediting	2008	649
Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma F. Stephen Hodi, Donald P. Lawrence, Cecilia Lezcano, Cancer Immunology Research ImmunologyImmunoeditingPathologyImmune Checkpoint BlockadeImmunotherapy	2014	595
Developing a Common Language for Tumor Response to Immunotherapy: Immune-Related Response Criteria Using Unidimensional Measurements Mizuki Nishino, Anita Giobbie‐Hurder, Maria Gargano, Clinical Cancer Research	2013	507
PD-1 Inhibitor–Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course Mizuki Nishino, Nikhil H. Ramaiya, Mark M. Awad, Clinical Cancer Research	2016	485
Clinical Activity of mTOR Inhibition With Sirolimus in Malignant Perivascular Epithelioid Cell Tumors: Targeting the Pathogenic Activation of mTORC1 in Tumors Andrew J. Wagner, Izabela Malinowska-Kołodziej, Jeffrey A. Morgan, Journal of Clinical Oncology Malignant DiseaseMtor InhibitionMedicinePharmacologyImmunology	2010	389
Revised RECIST Guideline Version 1.1: What Oncologists Want to Know and What Radiologists Need to Know Mizuki Nishino, Jyothi P. Jagannathan, Nikhil H. Ramaiya, American Journal of Roentgenology	2010	366
Metastatic Pattern of Bladder Cancer: Correlation With the Characteristics of the Primary Tumor Atul B. Shinagare, Nikhil H. Ramaiya, Jyothi P. Jagannathan, American Journal of Roentgenology	2010	266
Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab Sree Harsha Tirumani, Nikhil H. Ramaiya, Abhishek Keraliya, Cancer Immunology Research ImmunodeficienciesImmunologyPathologyRadiographic ProfilingDermatology	2015	250
Ipilimumab associated hepatitis: imaging and clinicopathologic findings Kyung Won Kim, Nikhil H. Ramaiya, Katherine M. Krajewski, Investigational New Drugs Autoimmune DiseaseViral HepatitisHistopathologyHepatitisPathology	2013	230

Page 1